Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...
With a diverse drug portfolio and a robust pipeline of ... of therapies across multiple clinical areas including oncology, ...
The drugmaker has won an appeal against NICE's recent final draft guidance on Sarclisa (isatuximab) as a regimen alongside ...
The 51-year-old from Northamptonshire, in central England, was diagnosed with incurable cancer in 2015. After he stopped ...
New Delhi: Reviewing the Phase III clinical trial protocol of the GZ402671 (Venglustat) presented by the pharma major Sanofi, ...
The US Food and Drug Administration (FDA) has announced it has approved colon cancer drug ... Zaltrap, developed by Sanofi and Regeneron Pharmaceuticals, will compete with Roche Holding AG ...
Access to innovation is proving increasingly difficult for UK cancer patients. Unpicking the policy barriers is important for ...
The expert panel further added, "The safety and efficacy data are to be deliberated in the presence of an independent expert ...
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
" I’m honored to join Innate Pharma at such a pivotal moment in its evolution,”said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. “ We achieved notable regul ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback